Director of Molecular Pathology and Pathology Informatics
Providence St. Joseph Health
Jun 18, 2024
Implementing CGP + HRD testing in-house in a large US Healthcare System
Presented at:
The Power of Comprehensive Genomic Profiling Testing
Speakers
-
Brian Piening, PhD
Associate Member at Earle A. Chiles Research Institute Technical Director Clinical Genomics at Providence St. Joseph Health
Abstract
Homologous recombination repair deficiency (HRD) is associated with response to poly-ADP-ribose polymerase inhibition (PARPi) therapy in advanced ovarian cancer. In combination with CGP, these analyses allow clinicians to maximize clinical information so that patients are matched with approved therapies or enrolled in relevant clinical trials.
In this workshop, a pathologist and laboratory director will discuss the impact of implementing a HRD assay at their institution. They will describe the details of implementing the assay, technical considerations for HRD testing, concordance with other HRD assays, and the added value of offering CGP and HRD testing in-house.
You May Also Like
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
APR 02, 2024 | 8:00 AM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...
FEB 15, 2024 | 8:00 AM
Macrophages can mediate phagocytosis of cancer cells and cytotoxic tumor killing, and engage in effective bidirectional interactions with components of the innate and adaptive immune system....
FEB 08, 2024 | 10:00 AM
High-content screening (HCS) is an imaging-based, multi-parametric strategy used in drug development that generates rich datasets through multiplexing strategically chosen fluorescent dyes a...
Loading Comments...
Finish Registering
-
SEP 03, 2024Microbiology Week Virtual Event Series 2024
-
SEP 18, 2024Cell Biology Virtual Event Series 2024
- See More
-
JUN 28, 2024
- See More
